Thrombomodulin alfa

Drug Profile

Thrombomodulin alfa

Alternative Names: MB-015; MR-33; TMD1-105; Trodulin

Latest Information Update: 02 Feb 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Unknown
  • Class Anti-inflammatories; Anticoagulants; Antithrombotics; Peptides; Platelet membrane glycoproteins; Recombinant proteins
  • Mechanism of Action Protein C stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Thrombosis
  • Discontinued Disseminated intravascular coagulation

Most Recent Events

  • 02 Feb 2004 No development reported - Preclinical for Thrombosis in USA (unspecified route)
  • 04 Dec 2002 Discontinued - Preregistration for Disseminated intravascular coagulation in Japan (unspecified route)
  • 22 Jun 1998 Phase-III clinical trials for Disseminated intravascular coagulation in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top